| Display title | SLC13A5 citrate transporter disorder |
| Default sort key | SLC13A5 citrate transporter disorder |
| Page length (in bytes) | 8,546 |
| Namespace ID | 0 |
| Page ID | 71789707 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of page watchers | Fewer than 30 watchers |
| Number of redirects to this page | 1 |
| Counted as a content page | Yes |
| Wikidata item ID | Q61913468 |
| Local description | Neurological disease |
| Central description | early infantile epileptic encephalopathy that has material basis in homozygous or compound heterozygous mutation in the SLC13A5 gene on chromosome 17p13 |
| Page views in the past 30 days | |
| Edit | Allow all users (no expiry set) |
| Move | Allow all users (no expiry set) |
| Page creator | Charles Matthews (talk | contribs) |
| Date of page creation | 03:26, 19 September 2022 |
| Latest editor | Citation bot (talk | contribs) |
| Date of latest edit | 08:15, 31 July 2024 |
| Total number of edits | 56 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |
| Hidden categories (2) | This page is a member of 2 hidden categories (help):
|
| Transcluded templates (32) | Pages transcluded onto the current version of this page (help):
|
| Wikidata entities used in this page | |
